Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. The REMAP-CAP Investigators New England Journal of Medicine, February, 2021.
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 [link]Paper  doi  bibtex   1 download  
@article{the_remap-cap_investigators_interleukin-6_2021,
	title = {Interleukin-6 {Receptor} {Antagonists} in {Critically} {Ill} {Patients} with {Covid}-19},
	issn = {0028-4793, 1533-4406},
	url = {http://www.nejm.org/doi/10.1056/NEJMoa2100433},
	doi = {10.1056/NEJMoa2100433},
	language = {en},
	urldate = {2021-02-28},
	journal = {New England Journal of Medicine},
	author = {{The REMAP-CAP Investigators}},
	month = feb,
	year = {2021},
	pages = {NEJMoa2100433},
}

Downloads: 1